BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising enhancements throughout different professional medical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, additional trusted substitute for the